Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 7, 2010; 16(25): 3187-3195
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3187
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3187
Figure 2 Association between thiopurine S-methyltransferase (TPMT) polymorphisms and all adverse drug reactions (ADRs) (A), bone marrow toxicity (B), hepatotoxicity (C) and pancreatitis (D).
Total: Total number of patients within the ADRs or no ADRs group; Events: Number of patients with one or more TPMT alleles within the ADRs or no ADRs group. neg assoc: Favoured the no ADRs group; pos assoc: Favoured the ADRs group.
- Citation: Dong XW, Zheng Q, Zhu MM, Tong JL, Ran ZH. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease. World J Gastroenterol 2010; 16(25): 3187-3195
- URL: https://www.wjgnet.com/1007-9327/full/v16/i25/3187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i25.3187